FINESSI, Valentina
 Distribuzione geografica
Continente #
NA - Nord America 473
EU - Europa 320
AS - Asia 85
Totale 878
Nazione #
US - Stati Uniti d'America 473
PL - Polonia 142
IT - Italia 94
CN - Cina 47
UA - Ucraina 26
TR - Turchia 20
GB - Regno Unito 18
DE - Germania 15
SG - Singapore 12
BE - Belgio 9
SE - Svezia 6
FI - Finlandia 5
ID - Indonesia 2
IR - Iran 2
NL - Olanda 2
VN - Vietnam 2
CZ - Repubblica Ceca 1
FR - Francia 1
RO - Romania 1
Totale 878
Città #
Warsaw 142
Ann Arbor 68
Chandler 60
Ferrara 54
Fairfield 38
Woodbridge 35
Ashburn 34
Jacksonville 33
Houston 32
Seattle 21
Cambridge 20
Wilmington 18
Izmir 16
Beijing 12
Brussels 9
Princeton 9
New York 8
Shanghai 8
Nanjing 6
Singapore 6
Boardman 5
San Diego 5
Cagliari 4
Milan 4
Washington 4
Modena 3
Redwood City 3
Rome 3
Shenyang 3
Tianjin 3
Amsterdam 2
Ardabil 2
Changsha 2
Dong Ket 2
Hebei 2
Jakarta 2
Jiaxing 2
Jinan 2
Leawood 2
Los Angeles 2
Nanchang 2
Bologna 1
Borgo Valsugana 1
Brno 1
Casale Monferrato 1
Changchun 1
Dearborn 1
Falls Church 1
Ferrara di Monte Baldo 1
Frankfurt am Main 1
Fuzhou 1
Hangzhou 1
Kilburn 1
Kunming 1
London 1
Mountain View 1
Norwalk 1
Orange 1
Osimo 1
Paris 1
Ravenna 1
Redmond 1
Salerno 1
San Severo 1
Taizhou 1
Tappahannock 1
Trani 1
Venezia 1
Wandsworth 1
Totale 716
Nome #
Ruolo della proteina Tat nell’infezione da HIV: studi in vitro e immunogenicità in vivo 188
The HIV-1 Tat protein induces the activation of CD8+ T cells and affects in vivo the magnitude and kinetics of antiviral responses. 148
Effects of different routes of administration on the immunogenicity of the Tat protein and a Tat-derived peptide 148
The HIV-1 Tat protein affects human CD4+ T cell programming and activation, and favors the differentiation of naïve CD4+ T cells 126
An Attenuated Herpes Simplex Virus Type 1 (HSV1) Encoding the HIV-1 Tat Protein Protects Mice from a Deadly Mucosal HSV1 Challenge 119
null 49
null 43
Use of a Novel Peptide Welding Technology Platform for the Development of B- and T-Cell Epitope-Based Vaccines 37
Viral Vector Expressing Tat As Immunomodulatory Molecule Represent A New Vaccine Strategy Against HSV Infection 24
HIV-1 Tat affects the programming and functionality of human CD8⁺ T cells by modulating the expression of T-box transcription factors 15
Totale 897
Categoria #
all - tutte 3.105
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 3.105


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/2020196 30 11 7 22 18 15 16 15 15 22 17 8
2020/2021168 19 13 7 12 14 16 9 23 11 21 16 7
2021/202296 5 14 1 7 2 1 12 1 3 9 9 32
2022/2023119 11 6 6 19 18 13 6 21 14 0 3 2
2023/202471 13 2 0 4 2 19 4 9 1 0 1 16
Totale 897